FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP...

16
FDA Regulation of Tobacco Washington , DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director, Legal and Policy Analysis, Campaign for Tobacco Free Kids Raymond S. Niaura, PhD, Associate Director for Science, Schroeder Institute for Tobacco Research and Policy Studies David Sweanor, Adjunct Professor, Faculty of Law, University of Ottawa Moderated by Jim Solyst, Vice President, Federal Regulatory Affairs, Swedish Match North America

Transcript of FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP...

Page 1: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

FDA Regulation of

Tobacco

Washington, DC

October 21, 2015

The Impact of MRTP – A look at the MRTP process, and the impact on products

Denny Henigan, Director, Legal and Policy Analysis, Campaign for Tobacco Free Kids

Raymond S. Niaura, PhD, Associate Director for Science, Schroeder Institute for Tobacco Research and Policy Studies

David Sweanor, Adjunct Professor, Faculty of Law, University of Ottawa

Moderated by Jim Solyst, Vice President, Federal Regulatory Affairs, Swedish Match North America

Page 2: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

THE IMPACT OF MRTP A Look at the MRTP Process and

the Impact on Products

Moderated by Jim Solyst

Vice President, Federal Regulatory Affairs

Swedish Match North America

Page 3: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

Status of the Swedish Match MRTP Application

• Submitted to FDA in June 2014 and determined to be complete in late August.

• The entire application, except for proprietary information, was made publicly available and there was an extended (nearly six months) review and comment period.

• As required by the Act, the FDA Tobacco Product Scientific Advisory Committee (TPSAC) met on April 9-10, 2015 to review the application and address questions posed by FDA CTP.

• Swedish Match and FDA provided briefing documents to the TPSAC. The Swedish Match document provides a readable version of the scientific evidence. The FDA document posed questions for the TPSAC to consider, and more importantly gives a sense of the Center’s thinking.

• FDA determined there needed to be a review and comment period for the eight “amendments” submitted by Swedish Match at the request of FDA.

Page 4: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

Possible Decisions and What Is Success?

• FDA could reject the MRTP application entirely; or decide to grant a MRTP order and accept the three suggested warning label changes.

• Or the decision will be something in between.• Granting a MRTP order, with or without the proposed warning label

changes, would be a historic development and certainly a “success” for proponents of tobacco harm reduction.

Page 5: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

What Would a MRTP Order Mean to Swedish Match?

• Would require a postmarket surveillance program.• Would allow the Company to communicate the meaning of the

MRTP order to the public and stakeholders.• Swedish Match would work with FDA to determine exactly what can

and cannot be communicated, but by granting a MRTP order, FDA has determined that:– Switching from cigarettes to General snus reduces an individual’s risk;

and

– The order benefits the health or the overall population.

Page 6: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

Evidence-Based Risk Communication: Right-to-know the Relative Risk

Ray Niaura, PhD

Director of Science and Training

Schroeder Institute for Tobacco Research and Policy Studies

Truth Initiative

Page 7: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

Risk Perceptions: Why?

Lights

PREPs

Snus

E-cigs/ENDS

MRTPs

Page 8: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

Winning hearts and minds?

Tan ASL, Bigman CA. E-cigarette awareness and perceived harmfulness: prevalence and

associations with smoking-cessation outcomes. Am J Prev Med 2014; 47: 141–9.

Perceived e-cig risk in young

British smokers

Trends in electronic cigarette use in young people in Great Britain over 2013-2014

Arnott, Britton, Cheeseman, Dockrell, Eastwood, Jarvis, & McNeill ASH, CR-UK, PHE

2014

Page 9: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

9

Page 10: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

10

Page 11: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,
Page 12: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

The Impact of MRTP-A look at the MRTP process, and the impact on

products

David SweanorAdjunct Professor, Faculty of Law

University of Ottawa

Page 13: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

WARNINGS AND MODIFIED RISK TOBACCO PRODUCTS

Dennis Henigan

Director, Legal and Policy Analysis

Campaign for Tobacco-Free Kids

Page 14: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

SMOKELESS WARNINGS SOUGHT BY RJ REYNOLDS CITIZEN PETITION

• WARNING: This product can cause mouth cancer.

• WARNING: This product can cause gum disease and tooth loss.

• WARNING: This product is not a safe alternative to cigarettes.

• WARNING: No tobacco product is safe, but this product presents substantially lower risks to health than cigarettes.

• Or WARNING: No tobacco product is safe; however, exclusive use of smokeless tobacco products presents substantially less risk to health than cigarettes.

• WARNING: Smokeless tobacco is addictive.

Page 15: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

SMOKELESS WARNINGS SOUGHT BY SWEDISH MATCH MODIFIED RISK

APPLICATION

• WARNING: This product can cause mouth cancer.

• WARNING: This product can cause gum disease and tooth loss.

• WARNING: This product is not a safe alternative to cigarettes.

• WARNING: No tobacco product is safe, but this product presents substantially lower risks to health than cigarettes.

• WARNING: Smokeless tobacco is addictive.

Page 16: FDA Regulation of Tobacco Washington, DC October 21, 2015 The Impact of MRTP – A look at the MRTP process, and the impact on products Denny Henigan, Director,

Source: Swedish Match Premarket Consumer Perception Survey Protocol, Appendix B: Research Stimuli